| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |